View ValuationVaso 将来の成長Future 基準チェック /06現在、 Vasoの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Medical Equipment 収益成長16.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Nov 20Nano-X Imaging Ltd. (NasdaqGM:NNOX) agreed to acquire VasoHealthcare IT Corp from Vaso Corporation (OTCPK:VASO) for $0.8 million.Nano-X Imaging Ltd. (NasdaqGM:NNOX) agreed to acquire VasoHealthcare IT Corp from Vaso Corporation (OTCPK:VASO) for $0.8 million on November 19, 2025. Under the terms of the proposed transaction, Nanox will acquire VHC IT for a total consideration of up to $0.8 million, consisting of a $0.2 million cash payment at closing and up to $0.6 million in performance-based earnout payments over a period of up to two years, contingent upon revenue retention targets with respect to existing customers. The transaction is expected to complete within a couple of weeks. Barley Snyder LLC acted as legal advisor to Vaso Corporation.お知らせ • Nov 06Vaso Corporation, Annual General Meeting, Dec 17, 2025Vaso Corporation, Annual General Meeting, Dec 17, 2025. Location: lever house, 390, park avenue, new york, ny 10022, United Statesお知らせ • Jan 13Vaso Corporation Elects Edgar Rios as Vice Chairman of Board of DirectorsVaso Corporation announced Edgar Rios was elected Vice Chairman of Board of Directors. Mr. Rios has served as an independent Director of Vaso since 2011. He will also continue in his role as Chairman of the Board’s Audit Committee.お知らせ • Jan 05Vaso Corporation Announces Executive ChangesVaso Corporation announced effective January 1, 2025, the board of directors appointed Jane Moen as its chief operating officer. Mr. Peter C. Castle, previously Chief Operating Officer, will continue in his capacity as President of the VasoTechnology Inc. Ms. Moen, age 45, has been a director of the Company since March 2020 and an executive officer of the Company since 2018. Ms. Moen has been President of the Vaso Diagnostics Inc. d/b/a VasoHealthcare, since June 2018 and will continue in that capacity. Effective January 1, 2025, Michael Beecher, previously Secretary, ceased serving in those role but will continue to be employed by the Company as a financial advisor. As a result, Jonathan Newton, previously Co-Chief Financial Officer and Treasurer of the Company, continues as the company’s sole Chief Financial Officer and Treasurer and was also appointed as the Secretary of the company.お知らせ • Dec 08Vaso Corporation (OTCPK:VASO) entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I (NasdaqGM:AVHI) from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction.Vaso Corporation (OTCPK:VASO) entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I (NasdaqGM:AVHI) from Achari Sponsor Holdings I LLC and others in a reverse merger transaction on September 12, 2023. Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction on December 6, 2023. Each share of common stock of Vaso issued and outstanding as of immediately prior to the Effective Time shall be automatically cancelled and extinguished and converted into the right to receive a number of shares of Achari’s common stock, in accordance with an exchange ratio set forth in the Business Combination Agreement and based on an equity value of Vaso of $176,000,000 and a price of $10 per share of the Achari Shares. Upon the closing of the Business Combination Agreement, it is anticipated that Achari will change its name to Vaso Holding Corp. Vaso common stock and warrants are expected to be listed on Nasdaq Capital Market ("Nasdaq") under the ticker symbols "VASO" and "VASOW", respectively. Vaso is led by Chief Executive Officer Jun Ma, who will continue to lead the combined company following the proposed business combination. If Agreement is terminated, then the non-terminating party shall pay to the terminating party an amount equal to $600,000. The obligations of Achari and Vaso to consummate the Business Combination is subject to various customary closing conditions, including the filing and effectiveness of a Registration Statement on Form S-4 (as amended or supplemented, the "Registration Statement") by Achari with the United States Securities and Exchange Commission ("SEC"), the filing and clearance by the SEC of a proxy statement by Vaso and the approval of the stockholders of both Achari and Vaso of the proposed business combination. The Boards of Directors of Vaso and Achari have each approved the Transaction. Ladenburg Thalmann & Co. Inc. is serving as financial, fairness opinion provider and capital markets advisor to Vaso. Timothy J. Kirby and Joshua A. Feiger of Katten Muchin Rosenman LLP acting as legal advisors to Achari and William Rosenstadt of Ortoli Rosenstadt LLP is acting as legal advisor to Vaso. Continental Stock Transfer & Trust Company will act as exchange agent to Achari.お知らせ • Oct 04Vaso Corporation, Annual General Meeting, Nov 15, 2022Vaso Corporation, Annual General Meeting, Nov 15, 2022, at 10:00 US Eastern Standard Time. Location: Grand Hyatt Tampa Bay Hotel, 2900 Bayport Drive, Tampa, Florida 33607 Florida United States Agenda: To discuss and approve election of two directors in class ii, to hold office until the 2025 annual meeting of stockholders; to discuss the ratification of the appointment of uhy llp as independent registered public accountants for the year ending December 31, 2022; and to discuss any other matters that properly come before the meeting.お知らせ • May 15Vaso Corporation announced delayed 10-Q filingOn 05/14/2021, Vaso Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Vaso Corporation announced delayed annual 10-K filingOn 03/30/2021, Vaso Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 13Vaso Corporation to Report Q2, 2020 Results on Aug 14, 2020Vaso Corporation announced that they will report Q2, 2020 results at 2:00 PM, GMT Standard Time on Aug 14, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Vaso は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:VASO - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026892N/AN/AN/A12/31/202589289N/A9/30/202589389N/A6/30/202587068N/A3/31/202587124N/A12/31/202487123N/A9/30/202482012N/A6/30/202481301N/A3/31/202481356N/A12/31/202381555N/A9/30/2023821289N/A6/30/202382121011N/A3/31/202381121313N/A12/31/202279111414N/A9/30/20228171515N/A6/30/20227951112N/A3/31/202276612N/A12/31/202176678N/A9/30/202170467N/A6/30/202169578N/A3/31/202169145N/A12/31/202070056N/A9/30/202075155N/A6/30/202076145N/A3/31/202077156N/A12/31/2019760N/A-1N/A9/30/201971-4N/A-2N/A6/30/201971-5N/A-2N/A3/31/201972-5N/A-2N/A12/31/201874-4N/A-1N/A9/30/201875-3N/A-1N/A6/30/201875-4N/A-2N/A3/31/201874-4N/A0N/A12/31/201773-5N/A2N/A9/30/201772-4N/A2N/A6/30/201771-2N/A3N/A3/31/201771-1N/A4N/A12/31/2016731N/A5N/A9/30/2016753N/A4N/A6/30/2016754N/A3N/A3/31/2016674N/A2N/A12/31/2015574N/A7N/A9/30/2015484N/A6N/A6/30/2015382N/A7N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: VASOの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: VASOの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: VASOの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: VASOの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: VASOの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: VASOの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/21 01:55終値2026/05/21 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Vaso Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 20Nano-X Imaging Ltd. (NasdaqGM:NNOX) agreed to acquire VasoHealthcare IT Corp from Vaso Corporation (OTCPK:VASO) for $0.8 million.Nano-X Imaging Ltd. (NasdaqGM:NNOX) agreed to acquire VasoHealthcare IT Corp from Vaso Corporation (OTCPK:VASO) for $0.8 million on November 19, 2025. Under the terms of the proposed transaction, Nanox will acquire VHC IT for a total consideration of up to $0.8 million, consisting of a $0.2 million cash payment at closing and up to $0.6 million in performance-based earnout payments over a period of up to two years, contingent upon revenue retention targets with respect to existing customers. The transaction is expected to complete within a couple of weeks. Barley Snyder LLC acted as legal advisor to Vaso Corporation.
お知らせ • Nov 06Vaso Corporation, Annual General Meeting, Dec 17, 2025Vaso Corporation, Annual General Meeting, Dec 17, 2025. Location: lever house, 390, park avenue, new york, ny 10022, United States
お知らせ • Jan 13Vaso Corporation Elects Edgar Rios as Vice Chairman of Board of DirectorsVaso Corporation announced Edgar Rios was elected Vice Chairman of Board of Directors. Mr. Rios has served as an independent Director of Vaso since 2011. He will also continue in his role as Chairman of the Board’s Audit Committee.
お知らせ • Jan 05Vaso Corporation Announces Executive ChangesVaso Corporation announced effective January 1, 2025, the board of directors appointed Jane Moen as its chief operating officer. Mr. Peter C. Castle, previously Chief Operating Officer, will continue in his capacity as President of the VasoTechnology Inc. Ms. Moen, age 45, has been a director of the Company since March 2020 and an executive officer of the Company since 2018. Ms. Moen has been President of the Vaso Diagnostics Inc. d/b/a VasoHealthcare, since June 2018 and will continue in that capacity. Effective January 1, 2025, Michael Beecher, previously Secretary, ceased serving in those role but will continue to be employed by the Company as a financial advisor. As a result, Jonathan Newton, previously Co-Chief Financial Officer and Treasurer of the Company, continues as the company’s sole Chief Financial Officer and Treasurer and was also appointed as the Secretary of the company.
お知らせ • Dec 08Vaso Corporation (OTCPK:VASO) entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I (NasdaqGM:AVHI) from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction.Vaso Corporation (OTCPK:VASO) entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I (NasdaqGM:AVHI) from Achari Sponsor Holdings I LLC and others in a reverse merger transaction on September 12, 2023. Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction on December 6, 2023. Each share of common stock of Vaso issued and outstanding as of immediately prior to the Effective Time shall be automatically cancelled and extinguished and converted into the right to receive a number of shares of Achari’s common stock, in accordance with an exchange ratio set forth in the Business Combination Agreement and based on an equity value of Vaso of $176,000,000 and a price of $10 per share of the Achari Shares. Upon the closing of the Business Combination Agreement, it is anticipated that Achari will change its name to Vaso Holding Corp. Vaso common stock and warrants are expected to be listed on Nasdaq Capital Market ("Nasdaq") under the ticker symbols "VASO" and "VASOW", respectively. Vaso is led by Chief Executive Officer Jun Ma, who will continue to lead the combined company following the proposed business combination. If Agreement is terminated, then the non-terminating party shall pay to the terminating party an amount equal to $600,000. The obligations of Achari and Vaso to consummate the Business Combination is subject to various customary closing conditions, including the filing and effectiveness of a Registration Statement on Form S-4 (as amended or supplemented, the "Registration Statement") by Achari with the United States Securities and Exchange Commission ("SEC"), the filing and clearance by the SEC of a proxy statement by Vaso and the approval of the stockholders of both Achari and Vaso of the proposed business combination. The Boards of Directors of Vaso and Achari have each approved the Transaction. Ladenburg Thalmann & Co. Inc. is serving as financial, fairness opinion provider and capital markets advisor to Vaso. Timothy J. Kirby and Joshua A. Feiger of Katten Muchin Rosenman LLP acting as legal advisors to Achari and William Rosenstadt of Ortoli Rosenstadt LLP is acting as legal advisor to Vaso. Continental Stock Transfer & Trust Company will act as exchange agent to Achari.
お知らせ • Oct 04Vaso Corporation, Annual General Meeting, Nov 15, 2022Vaso Corporation, Annual General Meeting, Nov 15, 2022, at 10:00 US Eastern Standard Time. Location: Grand Hyatt Tampa Bay Hotel, 2900 Bayport Drive, Tampa, Florida 33607 Florida United States Agenda: To discuss and approve election of two directors in class ii, to hold office until the 2025 annual meeting of stockholders; to discuss the ratification of the appointment of uhy llp as independent registered public accountants for the year ending December 31, 2022; and to discuss any other matters that properly come before the meeting.
お知らせ • May 15Vaso Corporation announced delayed 10-Q filingOn 05/14/2021, Vaso Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Vaso Corporation announced delayed annual 10-K filingOn 03/30/2021, Vaso Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 13Vaso Corporation to Report Q2, 2020 Results on Aug 14, 2020Vaso Corporation announced that they will report Q2, 2020 results at 2:00 PM, GMT Standard Time on Aug 14, 2020